Howard Slayen Sells 5,700 Shares of Aehr Test Systems (NASDAQ:AEHR) Stock

Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen sold 5,700 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $133.03, for a total transaction of $758,271.00. Following the transaction, the director directly owned 140,667 shares in the company, valued at approximately $18,712,931.01. This trade represents a 3.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Aehr Test Systems Stock Performance

Shares of NASDAQ AEHR opened at $134.06 on Friday. The firm has a market capitalization of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. The stock has a 50 day moving average price of $92.83 and a 200 day moving average price of $71.45. Aehr Test Systems has a 52-week low of $16.38 and a 52-week high of $147.40.

Key Stories Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Institutional Investors Weigh In On Aehr Test Systems

A number of institutional investors have recently added to or reduced their stakes in AEHR. Caitong International Asset Management Co. Ltd purchased a new position in Aehr Test Systems in the fourth quarter valued at about $25,000. Advocate Investing Services LLC purchased a new stake in shares of Aehr Test Systems during the second quarter valued at about $26,000. Sunbelt Securities Inc. purchased a new stake in shares of Aehr Test Systems during the third quarter valued at about $27,000. State of Wyoming bought a new stake in shares of Aehr Test Systems in the 2nd quarter valued at about $28,000. Finally, KBC Group NV bought a new stake in shares of Aehr Test Systems in the 1st quarter valued at about $30,000. Institutional investors own 69.69% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Zacks Research upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Lake Street Capital restated a “buy” rating and set a $110.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Finally, Weiss Ratings lowered shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $136.67.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.